hyperthyroidism is a condition in which the thyroid gland synthesizes and secretes thyroid hormone (thyroxine [T4] and triiodothyronine [T3]) in excess of physiologic need, driving an accelerated systemic metabolic rate. It is distinguished from the broader term thyrotoxicosis, which describes the clinical syndrome of excess circulating thyroid hormone from any source — including hyperthyroidism itself, exogenous hormone ingestion, or transient hormone release from an inflamed gland — whereas hyperthyroidism specifically implies the thyroid gland is overproducing hormone. Mechanistically, it results from either diffuse gland overstimulation (as in Graves’ disease, driven by TSH-receptor stimulating antibodies), autonomously functioning nodular tissue that escapes normal pituitary feedback, or ectopic/exogenous hormone sources. The hallmark biochemical pattern is a suppressed or undetectable TSH with elevated free T4 and/or T3. Clinically relevant subtypes coded most often include thyrotoxicosis with diffuse goiter, i.e., Graves’ disease (E05.00, E05.01), thyrotoxicosis with toxic single thyroid nodule (E05.10, E05.11), thyrotoxicosis with toxic multinodular goiter (E05.20, E05.21), thyrotoxicosis from ectopic thyroid tissue (E05.30, E05.31), and thyrotoxicosis factitia (E05.40, E05.41). hyperthyroidism is commonly confused with thyroid storm, which is not a separate diagnosis but a severe, life-threatening exacerbation of hyperthyroidism captured by the “with thyrotoxic crisis or storm” fifth character of the same E05 codes, and with hypothyroidism, its physiologic opposite, which reflects hormone deficiency rather than excess.
The word entered English circa 1895-1900 as hyperthyroidism (noun), assembled directly from hyper- + thyroid + -ism. The base term thyroid itself dates to the 1690s, borrowed from French thyroïde, from Latin thyreoides, from Greek thyreoeidēs — literally “shield-shaped,” a name applied because the gland’s two lobes resemble an ancient Greek shield. The root thyr/o- connects hyperthyroidism to the entire thyroid word family: thyroiditis (inflammation of the gland), thyroidectomy (surgical removal of the gland), thyromegaly (enlargement of the gland), and euthyroid (normal, balanced thyroid function). The prefix hyper- is highly productive in medical terminology, appearing in hypertension, hyperglycemia, hyperkalemia, hyperplasia, and hypercalcemia.
🔀 ALIASES / ALTERNATE TERMS
Hyperthyroid(adjective form — e.g., “hyperthyroid state,” “hyperthyroid crisis”)
Overactive thyroid(lay term for excess thyroid hormone production)
Thyrotoxicosis(closely related but technically broader syndromic term; often used interchangeably in clinical documentation, though it also covers non-glandular sources of excess hormone)
Graves’ disease(autoimmune etiologic subtype driven by TSH-receptor antibodies; E05.00 without crisis, E05.01 with thyrotoxic crisis or storm)
Toxic adenoma / toxic single thyroid nodule(etiologic subtype from a single autonomously functioning “hot” nodule; E05.10, E05.11)
Thyroid storm / thyrotoxic crisis(severe, acute, life-threatening exacerbation; captured by the “with crisis or storm” fifth character, e.g., E05.91)
Subclinical hyperthyroidism(mild biochemical form with suppressed TSH but normal free T4/T3; typically defaults to E05.90 absent further specification)
Factitious thyrotoxicosis(iatrogenic or self-induced form from excess exogenous thyroid hormone intake; E05.40, E05.41)
🔗 RELATED TERMS
Hypothyroidism — the opposite of hyperthyroidism; caused by insufficient thyroid hormone production, producing a decreased rather than accelerated metabolic rate.
Euthyroid — adjective describing normal thyroid hormone levels and function; the treatment target for a patient being managed for hyperthyroidism.
Thyrotoxicosis — shares the o- root; the broader clinical syndrome of excess circulating thyroid hormone, of which hyperthyroidism is the most common cause.
Thyroiditis — inflammatory condition (e.g., subacute or postpartum thyroiditis) that can transiently release stored hormone and cause thyrotoxicosis without true glandular overproduction.
Graves’ disease — the most common cause of hyperthyroidism, an autoimmune disease driven by thyroid-stimulating immunoglobulins that bind and activate the TSH receptor.
Thyroid storm — a decompensated, multiorgan exacerbation of hyperthyroidism; coded using the “with thyrotoxic crisis or storm” fifth character rather than as a separate diagnosis.
Goiter — diffuse or nodular enlargement of the thyroid gland; may or may not accompany hyperthyroidism and can occur with normal thyroid function.
Thyroid nodule — a discrete growth within the gland; may be autonomously functioning (“hot,” causing toxic adenoma) or non-functioning (“cold”).
TSH suppression — the key laboratory hallmark of hyperthyroidism; a low or undetectable thyroid-stimulating hormone level with elevated free T4 and/or T3.
Radioactive iodine ablation — a primary therapeutic and diagnostic nuclear medicine procedure used to treat or evaluate hyperthyroidism.
Thyroidectomy — surgical removal of thyroid tissue; the definitive treatment for hyperthyroidism refractory to medication or radioactive iodine.
CODING CORNER
🏥 ICD-10-CM CODES
Thyrotoxicosis with Diffuse Goiter (Graves’ Disease)
⚠️ Coding Note:E05 codes do not require laterality since the thyroid is a single, midline gland — specificity instead comes from correctly identifying the underlying etiology (diffuse goiter/Graves’ disease vs. toxic single nodule vs. toxic multinodular goiter vs. ectopic tissue vs. factitious ingestion) and from the fifth-character crisis designation. A frequent undercoding trap on outpatient and inpatient profee claims is missing the “with thyrotoxic crisis or storm” fifth character (e.g., E05.01, E05.11, E05.21, E05.91) when documentation uses phrases like “thyroid storm,” “decompensated hyperthyroidism,” or “impending crisis” instead of the literal ICD-10-CM wording — query the provider to confirm crisis status, since it affects severity and level-of-care support. Radioactive iodine therapy (79005) commonly requires prior authorization and is typically reported alongside a separate therapeutic radiopharmaceutical HCPCS supply code; confirm payer-specific bundling edits when a diagnostic thyroid scan (78013 or 78014) is performed the same day, as modifier -59/-XU may be required to unbundle the claim. When medication and radioactive iodine fail to control hyperthyroidism, surgical coding should distinguish a unilateral lobectomy (60220) from a total thyroidectomy (60240), the latter being the definitive procedure for Graves’ disease and large toxic multinodular goiters. Documentation should also be reviewed for coexisting Graves’ ophthalmopathy or dermopathy, which are reported with additional, separate codes rather than substituted for the E05 code.